Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced a positive outcome from the Data and Safety Monitoring Board (DSMB) review of its Phase 1/2 ArMaDa clinical trial for OCU410, a …
Ocugen’s Gene Therapy Shows Promise in Early Trial for Age-Related Macular Degeneration Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced its upcoming inclusion in the Russell 3000® Index, set to take effect after the market closes on June 28, 2024. This announcement …
Ocugen to Join Russell 3000 Index Amid Transformative Year Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the appointment of Greg Firestone as the company’s new Chief Commercial Officer. Firestone will oversee commercial operations, including key product launches, …
TELA Bio Appoints Greg Firestone as Chief Commercial Officer Read More
EXTON, PA — Innovative Solutions & Support, Inc. (NASDAQ: ISSC) has announced the recent appointment of Major General Garry Dean to its Board of Directors as an independent director, which …
Innovative Solutions & Support Appoints Major General Garry Dean to Board of Directors Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) recently released its financial results for the first quarter of 2024, revealing increased losses as the company advances its drug development programs.
Virpax Pharmaceuticals Reports Increased Losses Amid Promising Developments Read More EXTON, PA — Innovative Solutions & Support, Inc. (NASDAQ: ISSC) reported a robust financial performance for the second quarter of fiscal 2024, ending March 31, 2024. Net sales surged to …
Innovative Solutions & Support Reports Strong Q2 Financial Results Read More
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced a significant milestone in cancer treatment. The company recently dosed the first patient in its Phase 1 clinical trial of …
Carisma Therapeutics Launches First Human Trial for CAR-Monocyte Therapy Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced that Humana, a major U.S. health insurer, has updated its coverage policy to include adolescents aged 15-21 in response to …
Humana Pioneers Coverage Expansion for Adolescent Depression Treatment Following FDA Clearance Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced this week an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. This collaboration marks a critical step …
Verrica Pharmaceuticals and Torii Pharmaceutical Expand Collaboration to Combat Common Warts in Global Phase 3 Trial Read More
CHESTERBROOK, PA — Trevena Inc. (Nasdaq: TRVN), a biopharmaceutical company, spotlighted its first-quarter achievements and financial standing, underscoring advancements in its novel treatment for chronic pain and epilepsy and strategic …
Trevena Reports Progress in Pain and Epilepsy Treatment Development, Amid Financial Adjustments Read More